Achillion-Logo-150 (4).jpg
Achillion to Present at the Leerink Partners 5th Annual Global Healthcare Conference
February 08, 2016 16:05 ET | Achillion Pharmaceuticals, Inc.
NEW HAVEN, Conn., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion,...
Achillion-Logo-150 (4).jpg
Achillion Announces Appointments of Martha Manning as General Counsel and Amy Jennings as Head of Regulatory Affairs
February 03, 2016 06:05 ET | Achillion Pharmaceuticals, Inc.
NEW HAVEN, Conn., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced the addition of two members to the senior management team. Martha Manning, Esq.,...
Achillion-Logo-150 (4).jpg
Achillion Appoints Dr. Joel Barrish as Chief Scientific Officer
January 04, 2016 06:05 ET | Achillion Pharmaceuticals, Inc.
NEW HAVEN, Conn., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that Joel Barrish, Ph.D., has been named the Company’s Chief Scientific Officer...
Achillion-Logo-150 (4).jpg
Achillion Reports Third Quarter And Nine Month 2015 Financial Results
November 05, 2015 17:51 ET | Achillion Pharmaceuticals, Inc.
NEW HAVEN, Conn., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three and nine months ended September 30, 2015. For the...
Achillion-Logo-150 (4).jpg
Achillion to Present at the Credit Suisse 24th Annual Healthcare Conference
November 02, 2015 06:05 ET | Achillion Pharmaceuticals, Inc.
NEW HAVEN, Conn., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion,...
Achillion-Logo-150 (4).jpg
Achillion Announces That Janssen Has Initiated a Phase 2a Study to Evaluate the Combination of AL-335, Odalasvir (ACH-3102), and Simeprevir for the Treatment of Genotype 1 Chronic HCV
October 16, 2015 06:05 ET | Achillion Pharmaceuticals, Inc.
NEW HAVEN, Conn., Oct. 16, 2015 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Alios Biopharma Inc., part of the Janssen Pharmaceutical Companies (Janssen)...
Achillion-Logo-150 (4).jpg
Achillion Reports Second Quarter and Six Month 2015 Financial Results
August 10, 2015 06:05 ET | Achillion Pharmaceuticals, Inc.
NEW HAVEN, Conn., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three and six months ended June 30, 2015. For the second...